Ocular findings in patients with systemic sclerosis

Clinics

Volumn 66, Issue 3, 2011, Pages 379-385

  Gomes, Beatriz de A F ^a   Santhiago, Marcony R ^b   Magalhães, Priscilla ^a   Kara Jr , Newton ^c   de Azevedo, Mário N L ^a   Moraes Jr , Haroldo V ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ocular findings; Ocular manifestations; Ophthalmologic findings; Systemic scleroderma; Systemic sclerosis

Indexed keywords

ADULT; AGED; ARTICLE; BRAZIL; CROSS-SECTIONAL STUDY; EYE DISEASE; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; POPULATION AND POPULATION RELATED PHENOMENA; SYSTEMIC SCLEROSIS; VISUAL ACUITY;

ADULT; AGED; BRAZIL; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC MEASUREMENTS; EYE DISEASES; FEMALE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; VISUAL ACUITY; YOUNG ADULT;

EID: 79957625435     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000300003     Document Type: Article

References (62)

1. Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, et al. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford). 2008;47:1185-92, doi: 10.1093/rheumatology/ ken179.
2. Guiducci S, Distler O, Distler JH, Matucci-Cerinic M. Mechanisms of vascular damage in SSc-implications for vascular treatment strategies. Rheumatology (Oxford). 2008;47 (Suppl 5):v18-20, doi: 10.1093/rheumatology/ ken267.
3. Jinnin M. Mechanisms of skin fibrosis in systemic sclerosis. J Dermatol. 2010;37:11-25, doi: 10.1111/j.1346-8138.2009.00738.x.
4. Sakkas LI. New developments in the pathogenesis of systemic sclerosis. Autoimmunity. 2005;38:113-6, doi: 10.1080/16066350500095415.
5. Fujimoto M, Sato S. B lymphocytes and systemic sclerosis. Curr Opin Rheumatol. 2005;17:746-51, doi: 10.1097/01.bor.0000179945.73518.28.
6. West RH, Barnett AJ. Ocular involvement in scleroderma. Br J Ophthalmol. 1979;63:845-7.
7. Horan EC. Ophthalmic manifestations of progressive systemic sclerosis. Br J Ophthalmol. 1969;53:388-92.
8. Tailor R, Gupta A, Herrick A, Kwartz J. Ocular manifestations of scleroderma. Surv Ophthalmol. 2009;54:292-304, doi: 10.1016/j.survophthal. 2008.12.007.
9. No authors listed. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23:581-90, doi: 10.1002/art. 1780230510.
10. LeRoy EC, Black CM, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202-5.
11. Cutolo M, Pizzorni C, Secchi ME, Sulli A. Capillaroscopy. Best Pract Res Clin Rheumatol. 2008;22:1093-108, doi: 10.1016/j.berh.2008.09.001.
12. Van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969;82:10-4.
13. Homma M, Tojo T, Akizuki M, Yamagata H. Criteria for Syogren's syndrome in Japan. Scand J Rheumatol. 1986;18:26-7.
14. Manthrope R, Oxholm P, Prause JU, Schiødt M. The Copenhagen criteria for Syogren's syndrome. Scand J Rheumatol. 1986;18:19-21.
15. Dandona L, Dandona R, Srinivas M, Mandal P, John RK, McCarty CA, et al. Open-angle glaucoma in an urban population in southern India: the Andhra Pradesh eye disease study. Ophthalmology. 2000;107:1702-9, doi: 10.1016/S0161-6420(00)00275-X.
16. Dandona L, Dandona R, Mandal P, Srinivas M, John RK, McCarty CA, Rao GN. Angle-closure glaucoma in an urban population in southern India. The Andhra Pradesh eye disease study. Ophthalmology. 2000;107:1710-6, doi: 10.1016/S0161-6420(00)00274-8.
17. Reddy CV, Foster CS. Scleroderma. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology, vol. V. Philadelphia: WB Saunders. 1994:2919-24.
18. Krieg T, Takehara K. Skin disease: a cardinal feature of systemic sclerosis. Rheumatology (Oxford). 2009;48 Suppl 3:iii14-18, doi: 10.1093/ rheumatology/kep108.
19. Walker UA, Tyndall A, Czirják L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis. 2007;66:754-63, doi: 10.1136/ ard.2006.062901.
20. Hamaguchi Y. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J Dermatol. 2010;37:42-53, doi: 10.1111/j.1346-8138.2009.00762.x.
21. Bell S, Krieg T, Meurer M. Antibodies to Ro/SSA detected by ELISA: correlation with clinical features in systemic scleroderma. Br J Dermatol. 1989;121:35-41, doi: 10.1111/j.1365-2133.1989.tb01397.x.
22. Alarcon-Segovia D, Ibanez G, Hermandez-Ortiz J, Velázquez-Forero F, González-Jiménez Y. Sjogren's syndrome in progressive systemic sclerosis (scleroderma). Am J Med. 1974;57:78-85.
23. Kirkham TH. Scleroderma and Sjogren's syndrome. Br J Ophthalmol. 1969;53:131-33.
24. Lemp MA, Nichols KK. Blepharitis in the United States 2009: a surveybased perspective on prevalence and treatment. Ocul Surf. 2009;7(2 Suppl): S1-S14.
25. Fotouhi A, Hashemi H, Khabazkhoob M, Mohammad K. Prevalence and risk factors of pterygium and pinguecula: the Tehran Eye Study. Eye (Lond). 2009;23:1125-9.
26. Paula JS, Thorn F, Cruz AA. Prevalence of pterygium and cataract in indigenous populations of the Brazilian Amazon rain forest. Eye (Lond). 2006;20:533-6.
27. Garrido Neto T, Garrido C, Carvalho R C, Lima H C. [Pterygium frequency study in Salvador and Manaus Hospital] Rev. Bras. Oftalmol. 1996;55:683-6.
28. Hamideh F, Prete PE. Ophthalmologic manifestations of rheumatic diseases. Semin Arthritis Rheum. 2001;30:217-41, doi: 10.1053/sarh.2001. 16639.
29. Akman A, Akova YA, Yücel E, Aydin P. Granulomatous anterior uveitis in a patient with CREST syndrome. Ocul Immunol Inflamm. 2000;8:201-3.
30. Courtade M, Gicquel JJ, Mercie M, Vabres B, Dighiero P. [Granulomatous uveitis and CREST syndrome: a case study] J Fr Ophtalmol. 2004;27:918-20, doi: 10.1016/S0181-5512(04)96237-7.
31. David R, Ivry M. Focal chorioretinitis and iridocyclitis associated with scleroderma. Ann Ophthalmol. 1976;8:199-202.
32. De Andrés J, García-Delpech S, Pérez VL, Díaz-Llopis M, Udaondo P, Sánchez MT, et al. Bilateral infusion pump implants as therapy for refractory corneal ulcers in a patient with CREST syndrome: an interdisciplinary approach. Arch Ophthalmol. 2008;126:964-7, doi: 10.1001/ archopht.126.7.964.
33. Aleixo AL, Benchimol EI, Neves Ede S, Silva CS, Coura LC, Amendoeira MR. [Frequency of lesions suggestive of ocular toxoplasmosis among a rural population in the State of Rio de Janeiro] Rev Soc Bras Med Trop. 2009;42:165-9, doi: 10.1590/S0037-86822009000200014.
34. Sii F, Lee GA, Sanfilippo P, Stephensen DC. Pellucid marginal degeneration and scleroderma. Clin Exp Optom. 2004;87:180-4, doi: 10.1111/j. 1444-0938.2004.tb03172.x.
35. Emre S, Kayikçioǧlu O, Ateş H, Cinar E, Inceoǧlu N, Yargucu F, et al. Corneal hysteresis, corneal resistance factor, and intraocular pressure measurement in patients with scleroderma using the reichert ocular response analyzer. Cornea. 2010;29:628-31.
36. Zoega GM, Fujisawa A, Sasaki H, Kubota A, Sasaki K, Kitagawa K, et al. Prevalence and risk factors for cornea guttata in the Reykjavik Eye Study. Ophthalmology. 2006;113:565-9, doi: 10.1016/j.ophtha.2005.12.014.
37. Sakata K, Sakata LM, Sakata VM, Santini C, Hopker LM, Bernardes R, et al. Prevalence of glaucoma in a South brazilian population: Projeto Glaucoma. Invest Ophthalmol Vis Sci. 2007;48:4974-9, doi: 10.1167/iovs. 07-0342.
38. Yamamoto T, Maeda M, Sawada A, Sugiyama K, Taniguchi T, Kitazawa Y, et al. Prevalence of normal-tension glaucoma and primary open-angle glaucoma in patients with collagen diseases. Jpn J Ophthalmol. 1999;43:539-42.
39. Allanore Y, Parc C, Monnet D, Brézin AP, Kahan A. Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis. Ann Rheum Dis. 2004;63:1276-8, doi: 10.1136/ard.2003.013540.
40. Resch H, Garhofer G, Fuchsjäger-Mayrl G, Hommer A, Schmetterer L. Endothelial dysfunction in glaucoma. Acta Ophthalmol. 2009;87:4-12, doi: 10.1111/j.1755-3768.2007.01167.x.
41. Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, et al. The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol. 1977;106:17-32.
42. Athanasiov PA, Prabhakaran VC, Selva D. Non-traumatic enophthalmos: a review. Acta Ophthalmol. 2008;86:356-64, doi: 10.1111/j.1755-3768. 2007.01152.x.
43. Fernando BS, Cannon PS, Tumuluri K, Cook AE. Linear scleroderma as a rare cause of enophthalmos: a case report. J Med Case Reports. 2007;1:179, doi: 10.1186/1752-1947-1-179.
44. Kirkali PA, Kansu T, Sanac AS. Unilateral enophthalmos in systemic scleroderma. J Clin Neuroophthalmol. 1991;11:43-4.
45. Peter S, Dietrich H, Wick G. Investigations for retinopathy in an avian model for systemic sclerosis. Exp Eye Res. 2004;79:85-92, doi: 10.1016/j. exer.2004.02.012.
46. Ushiyama O, Ushiyama K, Yamada T, Koarada S, Tada Y, Suzuki N, et al. Retinal findings in systemic sclerosis: a comparison with nailfold capillaroscopic patterns. Ann Rheum Dis. 2003;62:204-7, doi: 10.1136/ ard.62.3.204.
47. Raja MS, Marshall T, Burton BJ. Acute central retinal artery occlusion presenting as CREST syndrome: a case report. Cases J. 2009;2:9, doi: 10. 1186/1757-1626-2-9.
48. Konuk O, Sengul O, Baran O, Tiftikcioglu Y, Gokhan G, Berati H. Ocular ischemic syndrome presenting as central retinal artery occlusion in scleroderma: brief report. Retina. 2006;26:102-4, doi: 10.1097/00006982-200601000-00017.
49. Minasian M, Stanford M, Graham E, Denton CP, Black C. Bilateral ischaemic retinal vasculopathy in scleroderma. Br J Ophthalmol. 2005;89:1064-5.
50. Proctor B, Chang T, Hay D. Parafoveal telangiectasia in association with CREST syndrome. Arch Ophthalmol. 1998;116:814-5.
51. Huerva V, Sánchez MC. Juxtafoveolar telangiectasis associated with CREST syndrome. Ocul Immunol Inflamm. 2008;16:195-7, doi: 10.1080/ 09273940802217867.
52. Wong TY, Mitchell P. The eye in hypertension. Lancet. 2007;369:425-35, doi: 10.1016/S0140-6736(07)60198-6.
53. Klein R, Klein BEK, Moss SE, Wang Q. Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol. 1994;112:92-8.
54. Yu T, Mitchell P, Berry G, Li W, Wang JJ. Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol. 1998;116:83-9.
55. Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, et al. International Eye Disease Consortium. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117:313-319. e1, doi: 10.1016/j.ophtha.2009.07.017.
56. Klein R, Sharrett AR, Klein BE, Chambless LE, Cooper LS, Hubbard LD, et al. Are retinal arteriolar abnormalities related to atherosclerosis? The Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol. 2000;20:1644-50.
57. Cutolo M, Pizzorni C, Sulli A. Capillaroscopy. Best Pract Res Clin Rheumatol. 2005;19:437-52, doi: 10.1016/j.berh.2005.01.001.
58. Gasser P, Bühler FR. Nailfold microcirculation in normotensive and essential hypertensive subjects, as assessed by video-microscopy. J Hypertens. 1992;10:83-6, doi: 10.1097/00004872-199201000-00013.
59. Lambova SN, Müller-Ladner U. The specificity of capillaroscopic pattern in connective autoimmune diseases. A comparison with microvascular changes in diseases of social importance: arterial hypertension and diabetes mellitus. Mod Rheumatol. 2009;19:600-5, doi: 10.1007/s10165-009-0221-x.
60. Cutolo M, Pizzorni C, Sulli A. Nailfold video-capillaroscopy in systemic sclerosis. Z Rheumatol. 2004;63:457-62, doi: 10.1007/s00393-004-0673-5.
61. Coleman P, Barnard NA. Congenital hypertrophy of the retinal pigment epithelium: prevalence and ocular features in the optometric population. Ophthalmic Physiol Opt. 2007;27:547-55, doi: 10.1111/j.1475-1313.2007. 00513.x.
62. Klein R, Cruickshanks KJ, Nash SD, Krantz EM, Javier Nieto F, Huang GH, et al. The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol. 2010;128:750-8, doi: 10.1001/ archophthalmol.2010.92.